Breaking the Cycle: A Pharmacist’s Role in Tackling Urea Cycle Disorders 12/3/24
Due to the low incidence of Urea Cycle Disorders, pharmacists may not be familiar with the presentation, treatment, or pharmacy-specific considerations for these potentially life-threatening disorders. This presentation seeks to educate pharmacy staff on clinical and operational information imperative for patients presenting with Urea Cycle Disorders.
Target Audience
Learning Objectives
Learning Objective 1: Describe the urea cycle and explain the pathophysiology and presentation of Urea Cycle Disorders (UCD)
Learning Objective 2: Evaluate the management of OTCD and examine pharmacy specific considerations
Learning Objective 3: Analyze novel therapies in development for UCD
Avery Jones, PharmD
In support of improving patient care, this activity has been planned and implemented by Children’s National Hospital. Children’s National Hospital is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Children’s National Hospital Accreditation Provider# 4008362.
Acknowledgement of Financial and In-Kind Commercial Support
No financial or in-kind commercial support was received for this educational activity.
Available Credit
- 1.00 ACPE PharmacistChildren's National Hospital is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This program meets ACPE criteria for 1.00 contact hours.
- 1.00 ACPE TechnicianChildren's National Hospital is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This program meets ACPE criteria for 1.00 contact hours.
- 1.00 ParticipationSuccessful completion of this continuing education activity.